Cholera outbreak in Mayotte (France): A retrospective description of 16 patients treated for hypovolemia in the ICU - 06/02/25
for the CHOLEMAY Study Group1
Highlights |
• | First French observational cohort of patients suffering from severe cholera. |
• | First series in an area with advanced intensive care facilities. |
• | Ongoing outbreak. |
Abstract |
Objectives |
To describe the presentation and therapeutic management of severe cholera in Mayotte (France).
Patients and methods |
We carried out retrospective data collection. All patients treated in the intensive care unit (ICU) with a confirmed diagnosis of cholera by PCR were studied. Only patients treated for hypovolemia were included.
Results |
Out of the 215 confirmed cases of cholera in Mayotte on July 12, 2024, 25 required treatment in the ICU (11.6 %). Among these cases, 16 were treated for hypovolemia (7.4 %), while five patients died of cholera before they could be admitted to hospital (lethality rate 2.3 %). No patient died in hospital.
Median patient age was 17 years (4–30) with a sex ratio of 1. Severe diarrhea was the rule with a median of one diarrheal stool every two hours. Clinical severity was characterized by sunken eyes and Glasgow Coma Scale (GCS) < 14 (n = 16/16,100 %). Biological severity was determined by profound metabolic acidosis with venous pH < 7.20 (n = 16/16, 100 %). Intravenous fluid therapy was aggressive with a median of 280 mL/kg (230–300) Ringer’s lactate solution during the first 48 h.
Conclusions |
Cholera can be a life-threatening infection, with deaths occurring due to severe diarrhea and hypovolemia. From the onset of symptoms, which are sometimes fulminant, patients must be admitted to a care center as soon as possible. We will continue to collect data to create scores that will enable us to better recognize the most severe forms of the disease.
Le texte complet de cet article est disponible en PDF.Keywords : Cholera, Outbreak, Intensive care, ICU
Plan
Vol 55 - N° 1
Article 105020- février 2025 Retour au numéro
Article précédent
- Estimating the number and incidence of carbapenemase-producing Enterobacterales infections in France in 2020: A capture-recapture study
- Mélanie Colomb-Cotinat, Amélie Jouzeau, Gaëlle Pedrono, Aurélie Chabaud, Christian Martin, Isabelle Poujol, Sylvie Maugat, Lory Dugravot, Catherine Dumartin, Anne Berger-Carbonne, Loïc Simon, Laurent Dortet
- Epidemiological and bacteriological trends from 2013 to 2023 of carbapenemase-producing enterobacterales (CPE) in a French university hospital: A permanent risk of outbreak
- Manon Robert, Stéphane Corvec, Anaïs Andreo, Florence Le Gallou, Géraldine Marquot, Reynald Mangeant, Céline Bourigault, Didier Lepelletier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?